Tag: PCAS
PCAS: capital increase of 200 ME
(CercleFinance.com) – PCAS has decided, as announced as part of the simplified public purchase offer initiated by Seqens, to increase the capital of PCAS for a total amount of 200…
Abnormal volumes on the Paris stock exchange: PCAS, McPhy Energy
During this stock market session on Friday, November 3, 2023, particularly high trading volumes were detected on the French market. Today, it is the PCAS share which stands out, with…
Unusual volumes on the stock market today: PCAS, Genfit
During this stock market session on Friday September 8, 2023, particularly high trading volumes were detected on the French market. Today, it is the PCAS share which stands out, with…
PCAS: Seqens launches an offer for minority interests – 09/07/2023 at 11:18
(CercleFinance.com) – PCAS, a specialist in complex molecules for the life sciences and technology sector, announced on Wednesday evening that Seqens, its majority shareholder, plans to launch a takeover bid…
PCAS: sale of the Canadian subsidiary confirmed
(CercleFinance.com) – After receiving an offer in early May, PCAS confirms that it has decided to sell its subsidiary PCAS Canada to the Japanese chemical group DIC Corporation, a sale…
PCAS: surrounded after an offer for the Canadian subsidiary
(CercleFinance.com) – PCAS jumped 11% after the announcement of a firm offer from the Japanese chemical group DIC Corporation for the acquisition of PCAS Canada. In this context, PCAS and…
PCAS: net loss widened in 2022
(CercleFinance.com) – PCAS publishes for 2022 a net result of -48.8 million euros, against -40.5 million in 2021, despite an EBITDA that rose from -4.6 to +2.2 million from a…
PCAS: net loss widened in 2022 – 03/31/2023 at 1:30 p.m.
(CercleFinance.com) – PCAS publishes for 2022 a net result of -48.8 million euros, against -40.5 million in 2021, despite an EBITDA that rose from -4.6 to +2.2 million from a…
PCAS: 2022 results will remain “very loss-making”
By Hector Chaunu Published on 21/12/2022 at 07:43 Photo credit © ChaunuPictures (Boursier.com)…
Pharmaceutical chemistry: Jean-Louis Martin appointed interim CEO of PCAS – 28/11/2022 at 18:33
(AOF) – The Board of Directors of PCAS, a company specializing in fine pharmaceutical chemicals, meeting on November 28, 2022, decided to appoint Jean-Louis Martin, current Vice-President Human Resources and…
PCAS: turnover up 9.6% over nine months – 11/04/2022 at 12:34
(CercleFinance.com) – PCAS, a producer of complex molecules for the life sciences and technology sectors, reported yesterday evening a turnover up 9.6% over the first nine months of exercise. As…
PCAS: €108.9 million in revenue for the first half – 09/09/2022 at 10:40 am
(CercleFinance.com) – PCAS announces the publication of its consolidated results for the first half of 2022. The consolidated revenue of the PCAS Group amounted to €109.8 million as of June…